Tomoya Tateishi Selected Research

Sarcoma (Soft Tissue Sarcoma)

1/2020

Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomoya Tateishi Research Topics

Disease

14	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 02/2024 - 03/2011
6	COVID-19 05/2023 - 01/2021
6	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2023 - 09/2015
5	Pneumonia (Pneumonitis) 05/2023 - 01/2015
4	Lung Diseases (Lung Disease) 02/2020 - 01/2015
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2023 - 07/2019
2	Bird Fancier's Lung 03/2023 - 12/2008
2	Dyspnea (Shortness of Breath) 03/2023 - 01/2018
2	Thrombosis (Thrombus) 01/2023 - 01/2021
2	Neoplasms (Cancer) 01/2023 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2021 - 02/2020
2	Idiopathic Pulmonary Fibrosis 07/2019 - 12/2008
2	Inflammation (Inflammations) 07/2019 - 01/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2024
1	Farmer's Lung 03/2023
1	Adenocarcinoma of Lung 01/2023
1	Weight Loss (Weight Reduction) 01/2022
1	Hypertension (High Blood Pressure) 06/2021
1	Hemorrhage 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2020
1	Pneumoconiosis 02/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Fibrosis (Cirrhosis) 07/2019
1	Idiopathic Interstitial Pneumonias 07/2019
1	Disease Progression 04/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2018
1	Emphysema 12/2018
1	Bronchiectasis 01/2016
1	Connective Tissue Diseases (Connective Tissue Disease) 09/2015
1	Vascular Diseases (Vascular Disease) 09/2015
1	Granuloma 01/2015

Drug/Important Bio-Agent (IBA)

12	AntigensIBA 02/2024 - 03/2011
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	CytokinesIBA 07/2019 - 05/2013
2	AntibodiesIBA 05/2023 - 01/2018
2	Methylcellulose (BFL)IBA 03/2023 - 12/2008
2	RNA (Ribonucleic Acid)IBA 09/2022 - 01/2022
2	fibrin fragment D (D-dimer)IBA 06/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 02/2020 - 01/2020
2	ChemokinesIBA 07/2019 - 05/2013
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 04/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2024
1	Signal Recognition ParticleIBA 05/2023
1	AutoantibodiesIBA 05/2023
1	Antiphospholipid AntibodiesIBA 01/2023
1	atezolizumabIBA 01/2023
1	sotorasibIBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	Cardiolipins (Cardiolipin)IBA 01/2023
1	PhosphatidylserinesIBA 01/2023
1	AutoantigensIBA 01/2023
1	Prothrombin (Factor II)IBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	A-factor (Streptomyces)IBA 09/2022
1	4- (3'- (2'- chlorophenyl)- 2'- propen- 1'- ylidene)- 1- phenyl- 3,5- pyrazolidinedioneIBA 01/2022
1	Interferon Type IIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	MetalsIBA 02/2020
1	TitaniumIBA 02/2020
1	titanium dioxide (Titania)FDA Link 02/2020
1	CosmeticsIBA 02/2020
1	NivolumabIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Carbon MonoxideIBA 07/2019
1	PeriostinIBA 07/2019
1	Matrix Metalloproteinases (MMPs)IBA 12/2018
1	Interleukin-4 (Interleukin 4)IBA 12/2018
1	Pancreatic Elastase (Elastase)IBA 12/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018
1	CollagenIBA 09/2015
1	Interleukin-17 (Interleukin 17)IBA 01/2015
1	CXC ChemokinesIBA 01/2015
1	LigandsIBA 01/2015

Therapy/Procedure

4	Therapeutics 04/2024 - 01/2020
2	Drug Therapy (Chemotherapy) 02/2020 - 01/2020
1	Humidifiers 01/2022
1	Lung Transplantation 04/2019
1	Traction 01/2016